rs149534094

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001848.3(COL6A1):​c.2866G>A​(p.Glu956Lys) variant causes a missense change. The variant allele was found at a frequency of 0.00156 in 1,611,122 control chromosomes in the GnomAD database, including 41 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0014 ( 2 hom., cov: 34)
Exomes 𝑓: 0.0016 ( 39 hom. )

Consequence

COL6A1
NM_001848.3 missense

Scores

5
13

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 5.30
Variant links:
Genes affected
COL6A1 (HGNC:2211): (collagen type VI alpha 1 chain) The collagens are a superfamily of proteins that play a role in maintaining the integrity of various tissues. Collagens are extracellular matrix proteins and have a triple-helical domain as their common structural element. Collagen VI is a major structural component of microfibrils. The basic structural unit of collagen VI is a heterotrimer of the alpha1(VI), alpha2(VI), and alpha3(VI) chains. The alpha2(VI) and alpha3(VI) chains are encoded by the COL6A2 and COL6A3 genes, respectively. The protein encoded by this gene is the alpha 1 subunit of type VI collagen (alpha1(VI) chain). Mutations in the genes that code for the collagen VI subunits result in the autosomal dominant disorder, Bethlem myopathy. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008347839).
BP6
Variant 21-46003792-G-A is Benign according to our data. Variant chr21-46003792-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 196953.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00143 (218/152376) while in subpopulation SAS AF= 0.00683 (33/4834). AF 95% confidence interval is 0.005. There are 2 homozygotes in gnomad4. There are 111 alleles in male gnomad4 subpopulation. Median coverage is 34. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL6A1NM_001848.3 linkc.2866G>A p.Glu956Lys missense_variant Exon 35 of 35 ENST00000361866.8 NP_001839.2 P12109A0A384P5H7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL6A1ENST00000361866.8 linkc.2866G>A p.Glu956Lys missense_variant Exon 35 of 35 1 NM_001848.3 ENSP00000355180.3 P12109

Frequencies

GnomAD3 genomes
AF:
0.00143
AC:
218
AN:
152258
Hom.:
2
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000523
Gnomad ASJ
AF:
0.0380
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.00682
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000485
Gnomad OTH
AF:
0.00191
GnomAD3 exomes
AF:
0.00291
AC:
720
AN:
247078
Hom.:
12
AF XY:
0.00323
AC XY:
434
AN XY:
134502
show subpopulations
Gnomad AFR exome
AF:
0.000127
Gnomad AMR exome
AF:
0.000377
Gnomad ASJ exome
AF:
0.0329
Gnomad EAS exome
AF:
0.0000554
Gnomad SAS exome
AF:
0.00921
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000613
Gnomad OTH exome
AF:
0.00463
GnomAD4 exome
AF:
0.00158
AC:
2300
AN:
1458746
Hom.:
39
Cov.:
34
AF XY:
0.00184
AC XY:
1337
AN XY:
725318
show subpopulations
Gnomad4 AFR exome
AF:
0.0000598
Gnomad4 AMR exome
AF:
0.000425
Gnomad4 ASJ exome
AF:
0.0367
Gnomad4 EAS exome
AF:
0.0000504
Gnomad4 SAS exome
AF:
0.00884
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000284
Gnomad4 OTH exome
AF:
0.00373
GnomAD4 genome
AF:
0.00143
AC:
218
AN:
152376
Hom.:
2
Cov.:
34
AF XY:
0.00149
AC XY:
111
AN XY:
74522
show subpopulations
Gnomad4 AFR
AF:
0.000144
Gnomad4 AMR
AF:
0.000522
Gnomad4 ASJ
AF:
0.0380
Gnomad4 EAS
AF:
0.000387
Gnomad4 SAS
AF:
0.00683
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000485
Gnomad4 OTH
AF:
0.00189
Alfa
AF:
0.00359
Hom.:
7
Bravo
AF:
0.00114
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00140
AC:
12
ExAC
AF:
0.00259
AC:
314
Asia WGS
AF:
0.00404
AC:
14
AN:
3478
EpiCase
AF:
0.00131
EpiControl
AF:
0.00107

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Aug 19, 2015
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Nov 17, 2016
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Jun 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

COL6A1: BS2 -

Bethlem myopathy 1A Benign:1
Jan 21, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Collagen 6-related myopathy Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Benign:1
Aug 08, 2024
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.16
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Benign
0.35
T;T
Eigen
Benign
-0.31
Eigen_PC
Benign
-0.19
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Benign
0.81
T;T
MetaRNN
Benign
0.0083
T;T
MetaSVM
Benign
-0.67
T
MutationAssessor
Benign
1.3
L;.
PrimateAI
Uncertain
0.76
T
PROVEAN
Uncertain
-2.6
D;.
REVEL
Uncertain
0.34
Sift
Benign
0.055
T;.
Sift4G
Benign
0.11
T;T
Polyphen
0.0080
B;.
Vest4
0.28
MVP
0.82
MPC
0.49
ClinPred
0.027
T
GERP RS
4.0
Varity_R
0.24
gMVP
0.50

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs149534094; hg19: chr21-47423706; COSMIC: COSV62614284; COSMIC: COSV62614284; API